A 48 Week Observational Study of the Frequency of Symptomatic Herpes Virus I and II in HIV Infected Subjects

Description

This study is an observational, cohort, prospective study looking at the frequency of Herpes Simplex Virus (HSV) 1 and or 2 outbreaks in HIV positive patients who's HIV virus is controlled on highly active anti-retroviral therapy. We will be enrolling fifty (50) patients.

Conditions

HIV Disease, Herpes Simplex 1, Herpes Simplex 2

Talk to us

Study Overview

On this page

Study Details

Study overview

This study is an observational, cohort, prospective study looking at the frequency of Herpes Simplex Virus (HSV) 1 and or 2 outbreaks in HIV positive patients who's HIV virus is controlled on highly active anti-retroviral therapy. We will be enrolling fifty (50) patients.

A 48 Week Observational Study of the Frequency of Symptomatic Herpes Virus I and II in HIV Infected Subjects

A 48 Week Observational Study of the Frequency of Symptomatic Herpes Virus I and II in HIV Infected Subjects

Condition
HIV Disease
Intervention / Treatment

-

Contacts and Locations

Los Angeles

Global Research Institute, Los Angeles, California, United States, 90036

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Subject must be 18 years or older at the time of screening
  • 2. Males, Females, Transgender Male and Transgender Females
  • 3. HIV positive
  • 4. Positive antibody to HSV- 1/and or HSV-2
  • 5. If Female of child baring potential, documented negative pregnancy test at the time of screening.
  • 1. Active opportunistic infection
  • 2. Current chemotherapy
  • 3. Unable to give informed consent

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Global Research Institute,

Study Record Dates

2025-04-01